Reaction
Macular Thickening reporting signals
As of the last recalculation, Macular Thickening appears in 77 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is FARICIMAB (PRR 900.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Faricimab | 20 | 900.8 | 903.0 |
| Aflibercept | 18 | 203.2 | 203.3 |
| Ranibizumab | 9 | 103.6 | 103.7 |